Transgene SA
F:TGNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Transgene SA
F:TGNA
|
FR |
|
International Stem Cell Corp
OTC:ISCO
|
US |
|
Townsquare Media Inc
NYSE:TSQ
|
US |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
U
|
United States Cellular Corp
F:US7
|
US |
|
P
|
Proximus NV
F:BX7
|
BE |
|
I
|
Installed Building Products Inc
SWB:2IL
|
US |
|
L
|
Leonardo SpA
DUS:FMNB
|
IT |
|
S
|
SNP Schneider Neureither & Partner SE
XMUN:SHF
|
DE |
|
Brookfield Wealth Solutions Ltd
TSX:BNT
|
BM |
|
Insmed Inc
NASDAQ:INSM
|
US |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
K
|
Kone Oyj
XMUN:KC4
|
FI |
Wall St Price Targets
TGNA Price Targets Summary
Transgene SA
According to Wall Street analysts, the average 1-year price target for
TGNA is 2.703 EUR with a low forecast of 2.008 EUR and a high forecast of 3.226 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TGNA's stock price target?
Price Target
2.703
EUR
According to Wall Street analysts, the average 1-year price target for
TGNA is 2.703 EUR with a low forecast of 2.008 EUR and a high forecast of 3.226 EUR.
What is the Revenue forecast for Transgene SA?
Projected CAGR
105%
Over the last 14 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 105%.